Lung health in LMICs: tackling challenges ahead
- PMID: 34364520
- DOI: 10.1016/S0140-6736(21)01230-7
Lung health in LMICs: tackling challenges ahead
Conflict of interest statement
EMK reports grants from the National Institute for Health Research Global Health Research Unit on Respiratory Health (RESPIRE) and Seqirus UK; and personal fees from AstraZeneca and GlaxoSmithKline. EMK is also board director of the International Primary Care Respiratory Group. RJ reports personal fees from Boehringer Ingelheim. All other authors declare no competing interests. We thank Aziz Sheikh (Usher Institute, University of Edinburgh, Edinburgh, UK), Ioanna Tsiligianni (Department of Social Medicine, Faculty of Medicine, Crete, Greece), and Siân Williams (International Primary Care Respiratory Group, Edinburgh, UK), who contributed to the conception of our Correspondence and participated in and guided our discussions.
Comment in
-
Lung health in LMICs: tackling challenges ahead - Authors' reply.Lancet. 2021 Aug 7;398(10299):490. doi: 10.1016/S0140-6736(21)01252-6. Lancet. 2021. PMID: 34364524 No abstract available.
Comment on
-
Improving lung health in low-income and middle-income countries: from challenges to solutions.Lancet. 2021 Mar 6;397(10277):928-940. doi: 10.1016/S0140-6736(21)00458-X. Epub 2021 Feb 22. Lancet. 2021. PMID: 33631128 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical